Who does use ENDS in Russia? Results from Russian tobacco control policy evaluation survey EPOCHA-RF
Abstract
Electronic Nicotine Delivery Systems (ENDS) become popular in Russia. Still little is known about use of these products.
To assess patterns of active and passive exposure to ENDS in Russian population.
Data from Russian tobacco control policy evaluation survey (2017-2018) are analysed, conducted on the basis of multistage territorial random sample of 11625 respondents: 6569 smokers, 2377 former smokers and 2679 never smokers 18years and older in 10 Russian Federal subjects.
38.8% of the respondents were familiar with ENDS, with the highest proportion in the youngest age group (18-24): 53.8%(p<.0001). 9.3%had tried ENDS, among 18-24 years old - those were 23.5%(p<.0001). The amount was significantly higher among recent quitters (in last 3years)-17.2%, and current smokers-13% compared with former (quitters for more than 3years) and never smokers. Of those 26.4% used ENDS regularly-with highest proportion among 18-24years old (29.1%), and current smokers (27.1%). This comprises 2.5% of respondents as regular ENDS users, and 6.8%-among the youngest group. Half of the smokers had tried to quit by means of ENDS, of those 69% failed to quit smoking, and 79% could neither give up smoking nor ENDS. However, only 18% ENDS users agreed that e-cigarettes cause addiction, and 37% even denied the fact. Those were mostly the youngest respondents (45%). Vaping was not allowed at homes of 67.4%respondents, at workplaces-of 65.6%. 14% of respondents had witnessed vaping at workplaces, 55.8%…
Read the paper
Related studies
- Tobacco and COPD: presenting the World Health Organization (WHO) Tobacco Knowledge Summary
- Comparative effects of e-cigarette smoking on periodontal status, salivary pH, and cotinine levels
- Association between exposure to environmental pollutants and increased oral health risks, a comprehensive review
- Influence of gestational window on offspring vascular health in rodents with in utero exposure to electronic cigarettes
- Natural products as kinase inhibitors in lung cancer: molecular mechanisms, therapeutic potential, and clinical trials
- Nicotine in electronic cigarettes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.